Michael Secora - Chief Financial Officer @ Recursion Pharmaceuticals

Overview

Number of Portfolio Companies

CB Rank (Investor)

Michael Secora is the Chief Financial Officer at Recursion Pharmaceuticals.

Number of Investments

invested in

obfuscation

. This investment -

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Noetik	—	Seed Round - Noetik	obfuscated obfuscation

Number of Current Jobs

has

current jobs as

Chief Financial Officer

and

Chief Corporate Development Officer and Chief Financial Officer

Hub Name	CB Rank (Hub)
Casdin Capital Portfolio Companies	63,788
GRIDS Capital Portfolio Companies	100,491
Salt Lake City Companies With Fewer Than 1000 Employees	20,745
Utah Companies With More Than 100 Employees	21,682
Menlo Ventures Portfolio Companies	69,490
Utah Companies With More Than $50M in Revenue	40,200
Catalio Capital Management Portfolio Companies	65,121
Artificial Intelligence (AI) Public Companies With Less Than $1B in Revenue	41,998
Invus Portfolio Companies	58,853
Pharmaceutical Public Companies With More Than $10M in Revenue	36,787

Funding Round•

Sep 7, 2023

Noetik raised

obfuscation

from 11.2 Capital and 11 other investors